Literature DB >> 26204865

In vitro hemodynamic characterization of HeartMate II at 6000 rpm: Implications for weaning and recovery.

Gengo Sunagawa1, Nicole Byram1, Jamshid H Karimov1, David J Horvath1, Nader Moazami2, Randall C Starling3, Kiyotaka Fukamachi4.   

Abstract

OBJECTIVES: Pump-off testing to assess left ventricular recovery is not an option for continuous-flow left ventricular assist devices unless measures are taken to prevent pump regurgitation. The purpose of this bench study was to characterize the hemodynamics and pump flow of the HeartMate II (Thoratec Corp, Pleasanton, Calif) left ventricular assist device at 6000 rpm, the speed commonly used clinically to determine left ventricular recovery.
METHODS: The HeartMate II device was operated in a mock loop at 3 speeds (6000, 8000, and 10,000 rpm). We acquired pressure-flow curves in each steady state. In pulsatile mode with the pneumatic ventricle (heart simulator) activated, pump flow, total flow, and aortic pressure data were obtained under conditions simulating normal heart function or heart failure.
RESULTS: A large regurgitant flow during diastole was confirmed in normal heart function at 6000 rpm support; however, the net flow was zero, and there were no differences in the mean aortic pressure between 6000 rpm support and no left ventricular assist device support. In contrast, in the heart failure condition, left ventricular assist device flow at 6000 rpm significantly contributed to the mean aortic pressure and total flow because there was less regurgitant flow.
CONCLUSIONS: The net pump flow generated by the HeartMate II device at 6000 rpm depends on the degree of residual left ventricular function. In the setting of improved left ventricular function, at 6000 rpm, we noted a large regurgitant flow that reloaded the left ventricle. Although this "marker" can serve as a useful indicator for left ventricular recovery, assessing left ventricular recovery at this speed is flawed unless measures are taken to prevent regurgitant flow.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted circulation; device removal; heart-assist devices; left; prosthesis design; risk factors; ventricular function

Mesh:

Year:  2015        PMID: 26204865     DOI: 10.1016/j.jtcvs.2015.04.015

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Universal ventricular assist device for right and left circulatory support: the Cleveland Clinic concept.

Authors:  Jamshid H Karimov; Anthony R Polakowski; Kiyotaka Fukamachi; Takuma Miyamoto; Christine Flick
Journal:  Ann Cardiothorac Surg       Date:  2021-03

2.  Characterization and Development of Universal Ventricular Assist Device: Computational Fluid Dynamics Analysis of Advanced Design.

Authors:  Mark S Goodin; Michael S Showalter; David J Horvath; Barry D Kuban; Christine R Flick; Anthony R Polakowski; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  ASAIO J       Date:  2021-11-10       Impact factor: 3.826

3.  An advanced universal circulatory assist device for left and right ventricular support: First report of an acute in vivo implant.

Authors:  Takuma Miyamoto; Yuichiro Kado; David J Horvath; Barry D Kuban; Shiva Sale; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  JTCVS Open       Date:  2020-06-20

4.  Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support.

Authors:  Andre Critsinelis; Chitaru Kurihara; Masashi Kawabori; Tadahisa Sugiura; Andrew B Civitello; Jeffrey A Morgan
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-08-28       Impact factor: 1.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.